Financials

  • Market Capitalization 10.52 M
  • Employee 8
  • Founded 2011
  • CEO Paul Kang
  • Website www.exicuretx.com
  • Headquarter Delaware, United States
  • FIGI BBG00GTJCSB4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-6.86
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4796
KPRX
Kiora Pharmaceuticals, Inc. - Common Stock
2.49 USD+1.22%-2.73%-2.35%+18.57%11.04 M USD
4802
TRAW
Traws Pharma, Inc. - Common Stock
0.70 USD+2.94%-6.67%-35.78%-54.84%10.61 M USD
4806
TOVX
Theriva Biologics, Inc. Common Stock
0.24 USD+4.35%+4.35%-17.24%-3.07%11.01 M USD
4811
VTGN
Vistagen Therapeutics, Inc. - Common Stock
0.25 USD0.00%+8.70%-57.63%-51.47%10.26 M USD

Notizie